Skip to content

JN-RD: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

JN-RD

BE 0778.830.420
NACE 72.101, Research and development on biotechnology
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€795
2024 · €21,237-€22,032
Equity
€67,273
2024 · €68,067-€794
Cash
€67,657
2024 · €82,322-€14,665
Balance sheet total
€67,834
2024 · €82,499-€14,665

Largest movements

2024 to 2025
Assets
  • Cash -€14,665

    down €14,665 (-17.8%), from €82,322 to €67,657

    mainly Tax, wage and social debts (-€7,461) and Trade debts (-€5,338)

Equity and liabilities
  • Tax, wage and social debts -€7,461

    no longer reported in 2025 (was €7,461)

  • Trade debts -€5,338

    down €5,338 (-95.8%), from €5,572 to €234

  • Other debts -€1,072

    down €1,072 (-76.6%), from €1,399 to €327

Income statement
  • Gross operating margin -€31,431

    down €31,431, from €30,778 to -€653

  • Taxes -€9,494

    down €9,494, from €9,005 to -€489

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €21,237
Gross operating margin -€31,431
Other operating charges -€78
Financial charges -€17
Taxes +€9,494
Result 2025 -€795

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€14,666
Investment €0
Financing +€1
Cash 2024 €82,322
Net result for the year -€795
Trade debts -€5,338
Tax, wage and social debts -€7,461
Other debts -€1,072
Contributions, distributions and other +€1
Cash 2025 €67,657
Every line side by side 25 lines
Line Code 2024 2025 Change %
Total assets 20/58 €82,499 €67,834 -€14,665 -17.8%
Current assets 29/58 €82,499 €67,834 -€14,665 -17.8%
Amounts receivable within one year 40/41 €177 €177 = 0.0%
Trade receivables 40 €177 €177 = 0.0%
Cash at bank and in hand 54/58 €82,322 €67,657 -€14,665 -17.8%
Total equity and liabilities 10/49 €82,499 €67,834 -€14,665 -17.8%
Equity 10/15 €68,067 €67,273 -€794 -1.2%
Contributions 10/11 €40,000 €40,000 = 0.0%
Profit (loss) carried forward 14 €28,067 €27,273 -€794 -2.8%
Amounts payable 17/49 €14,432 €561 -€13,871 -96.1%
Amounts payable within one year 42/48 €14,432 €561 -€13,871 -96.1%
Trade debts 44 €5,572 €234 -€5,338 -95.8%
Suppliers 440/4 €5,572 €234 -€5,338 -95.8%
Taxes, remuneration and social security 45 €7,461 - -€7,461
Taxes 450/3 €7,461 - -€7,461
Other amounts payable 47/48 €1,399 €327 -€1,072 -76.6%
Other operating charges 640/8 €387 €465 +€78 +20.2%
Gross operating margin 9900 €30,778 -€653 -€31,431
Operating profit (loss) 9901 €30,391 -€1,118 -€31,509
Financial charges 65/66B €149 €166 +€17 +11.4%
Recurring financial charges 65 €149 €166 +€17 +11.4%
Profit (loss) for the period before taxes 9903 €30,242 -€1,284 -€31,526
Income taxes 67/77 €9,005 -€489 -€9,494
Profit (loss) for the period 9904 €21,237 -€795 -€22,032
Profit (loss) for the period to be appropriated 9905 €21,237 -€795 -€22,032

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.